CT-guided biopsy in suspected spondylodiscitis: microbiological yield, impact on antimicrobial treatment, and relationship with outcome

Research output: Contribution to journalArticleAcademicpeer-review

22 Citations (Scopus)
251 Downloads (Pure)

Abstract

Purpose To investigate the clinical impact of CT-guided biopsy, as performed in routine clinical practice, in patients with suspected spondylodiscitis on MRI in terms of culture yield, impact on antimicrobial treatment, and outcome.

Methods This study included 64 patients with MRI findings compatible with spondylodiscitis who underwent CT-guided biopsy.

Results Initial CT-guided biopsies were culture-positive in 20/64 (31.3%, 95% confidence interval [CI] 21.2-43.3%). Repeat CT-guided biopsies (after initial negative biopsy) were culture-positive in an additional 5/15 (33.3%, 95% CI 15.2-58.3%). Serum leukocytes, C-reactive protein, pre-biopsy use of antibiotics, neurological symptoms, MRI findings, vertebral height loss, and hyperkyphosis were not significantly different between culture-positive and culture-negative cases (P = 0.214-1.000); 75% (15/20) of initial CT-guided biopsies that were culture-positive provided additional information to clinicians for guiding antibiotic treatment. Sixty-two of 64 patients (96.9%, 95% CI 89.3-99.1%) would have been adequately treated if a strategy was followed that would subject all patients without clinical findings suspicious for "atypical" microorganisms and negative blood cultures to empirical antibiotics (i.e., clindamycin for coverage of Gram-positive bacteria) without using biopsy results to determine the optimal antibiotic regimen. Outcome within 6 months (development of neurologic or orthopedic complications, surgery, and death) was not significantly different (P = 0.751) between culture-positive and culture-negative patients.

Conclusions Although CT-guided biopsies are culture-positive in a minority of cases, the majority of positive cultures are useful to tailor antibiotic treatment. Empirical treatment with clindamycin may cover almost all micro-organisms in positive biopsy specimens, provided patients are not immunocompromised. Outcome appears similar between culture-positive and culture-negative patients.

Original languageEnglish
Pages (from-to)1383-1391
Number of pages9
JournalSkeletal Radiology
Volume47
Issue number10
DOIs
Publication statusPublished - Oct-2018

Keywords

  • Biopsy
  • CT
  • Culture yield
  • Spondylodiscitis
  • Spine infection
  • PYOGENIC VERTEBRAL OSTEOMYELITIS
  • CLINICAL-PRACTICE GUIDELINES
  • INFECTIOUS-DISEASES SOCIETY
  • DIAGNOSIS
  • ADULTS(A)
  • KYPHOSIS
  • SPINE

Cite this